TAO Synergies Secures $11 Million in Series E Financing to Expand Bittensor Investments
TAO Synergies, a company focused on the Bittensor ecosystem, has successfully raised $11 million through a Series E financing agreement. This funding was secured via a securities purchase agreement that involved the sale of 11,000 shares of newly issued Series E convertible preferred stock, each valued at $1,000. The financing aims to bolster the firm’s strategic investments in Bittensor tokens and other revenue-generating opportunities. Notably, the agreement saw participation from existing investors and a new partner, Digital Currency Group (DCG), and is expected to close around October 15, 2025, pending standard closing requirements.
James Altucher, the digital asset strategy advisor for TAO Synergies, played a significant role in this financing deal. He emphasized that the funding would empower the company to continue its strategic investments in Bittensor tokens and related projects. The firm is committed to staking the TAO tokens it acquires, which not only generates rewards from the Bittensor network but also enhances its stake in this burgeoning ecosystem. This strategic pivot reflects TAO Synergies’ transition from its previous identity as Synaptogenix to a player in the cryptocurrency and AI sectors, aligning with its new ticker symbol, TAOX.
Following the announcement of the financing deal, TAO Synergies experienced a remarkable 38.46% surge in its stock price, reaching $9.54 per share. This increase occurred after market hours, and over the past month, the stock has climbed 60%, indicating heightened investor interest. With a current market capitalization of $33.27 million, TAO Synergies stands as the largest publicly traded holder of Bittensor, holding over $18 million in TAO tokens. The recent funding positions the firm to strengthen its presence in the Bittensor ecosystem while exploring further growth opportunities in the intersection of AI and blockchain technologies.
Related News





